Things To Consider Prior To Purchasing A Health Insurance In India
In the modern era of inflation, it becomes imperative to seek out a decent health insurance cover especially if you wish to safeguard yourself as well as your loved ones from falling prey to skyrocketing healthcare expenses. Apart from providing you with adequate peace of mind, it also offers the best chance of recovering back both physically and financially if anything unfortunate happens....
Daily Market Analysis – 22nd Oct 2020
Ecommerce Giant Amazon and Walmart owned Flipkart Group had a separate discussion with Aditya Birla Fashion & Retail (which owns brands like Pantaloons, Allen Solly & Peter England) to acquire a minor stake. According to the sources, offline retailers specifically in the fashion & apparel segment, have been severely hit by the covid 19 pandemic & the resulting...
SEBI intervenes to restructure Multi Cap Funds
SEBI takes steps to protect the interest of investors, to promote the development and to regulate the securities market. Keeping this objective in mind, SEBI issued a circular revamping the asset allocation for Multicap funds. As per the new guidelines, multicap funds would have to invest atleast 75% of the total assets in equity investments. SEBI also mentioned minimum limits of sub...
Daily Market Analysis – 21st Oct 2020
Hindustan Unilever (HUL) Q2 earnings beat estimates. HUL profit rises by 8.7% to Rs. 2,009 crore compared to Rs. 1,848 crore in the same period last year. Revenue from operations increased by 16.1% to Rs. 11,442 cr in Q2FY21 compared to Rs. 9,852 cr in the corresponding period last fiscal year. The operations and service levels of the company are now back to Pre- COVID levels and have...
Daily Market Analysis – 20th Oct 2020
Dr. Reddy’s receives DCGI approval to conduct phase 2/3 trials of the Sputnik V vaccine in India Dr. Reddy’s Laboratories (DRL) has received regulatory approval from the Drugs Controller General of India (DCGI) to conduct mid-to-late-stage human trials for Russia’s Sputnik V vaccine candidate in India. The developments bring India a step closer to potentially getting a Covid-19 vaccine by...
Daily Market Analysis – 19th Oct 2020
The Asian markets have started at a higher note on Monday, on the hopes of a US fiscal package before the US presidential elections in November 2020, and expectations of a coronavirus vaccine by the end of this year. Boosting the overall sentiment, drug maker Pfizer Inc said on Friday it could have a coronavirus vaccine ready in the United States by the end of this year. In the global...
Daily Market Analysis – 16th Oct 2020
1. Oil falls as possible OPEC+ supply boost, COVID-19 spike weigh on sentiment A technical committee of the Organization of the Petroleum Exporting Countries (OPEC) and allied oil producers, a group known as OPEC+, ended a meeting on Thursday expressing concerns about rising oil supply as social restrictions to curb the spread of COVID-19 limit fuel usage. OPEC+ is set to reduce its...
Daily Market Analysis – 14th Oct 2020
WIPRO reported a dollar revenue growth of 3.75 at $ 1,992.4 million against $ 1,921.6 million QoQ. Management expects dollar revenue growth at 1.5-3.5% inQ3. The company announced a buyback of shares worth Rs. 9,500 Crs at Rs. 400 per share. Future outlook: The company said that it has signed a definitive agreement to acquire Eximius Design, a leading engineering services company...
Daily Market Analysis – 13th Oct 2020
To make home loans cheaper, the Reserve Bank of India said that it will rationalise the risk weights and link them to Loan-to-Value (LTV) ratios for new housing loans sanctioned up to March 31, 2022. What it means is that banks are given a leeway while giving out larger housing loans. With reduced risk weights for loans above ₹75 lakh, the cost of lending to this customer segment will come...
